Your browser doesn't support javascript.
loading
Synthesis of new sulfated disaccharides for the modulation of TLR4-dependent inflammation.
Naïtaleb, Rachid; Denys, Agnès; Allain, Fabrice; Ausseil, Jérôme; Toumieux, Sylvestre; Kovensky, José.
Afiliação
  • Naïtaleb R; Laboratoire de Glycochimie, des Antimicrobiens et des Agroressources, LG2A CNRS UMR 7378, Université de Picardie Jules Verne, 33 rue Saint Leu, 80039 Amiens, France. jose.kovensky@u-picardie.fr sylvestre.toumieux@u-picardie.fr.
Org Biomol Chem ; 19(19): 4346-4351, 2021 05 21.
Article em En | MEDLINE | ID: mdl-33908564
ABSTRACT
Natural sulfated glycans are key players in inflammation through TLR4 activation; therefore synthetic exogenous sulfated saccharides can be used to downregulate inflammation processes. We have designed and synthesized new sulfated compounds based on small and biocompatible carbohydrates that are able to cross the BBB. A suitable protected donor and acceptor, obtained from a unique precursor, have been stereoselectively glycosylated to give an orthogonally protected cellobiose disaccharide. Selective deprotection and sulfation allowed the syntheses of four differentially sulfated disaccharides, which have been characterized by NMR, HRMS and MS/MS. Together with their partially protected precursors, the new compounds were tested on HEK-TLR4 cells. Our results show the potential of small oligosaccharides to modulate TLR4 activity, confirming the need for sulfation and the key role of the 6-sulfate groups to trigger TLR4 signalization.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dissacarídeos Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dissacarídeos Idioma: En Ano de publicação: 2021 Tipo de documento: Article